Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | MGLL | Q99685 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29418151 | 1.00 | GPR3 (0.54) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL25695863 | 0.91 | MAPT (0.44) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL24398652 | 0.90 | KDM4E (0.54) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL25490982 | 0.89 | MAPT (0.44) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL31818 | 0.89 | GPR3 (0.54) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL23620776 | 0.86 | MGLL (0.50) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL19961749 | 0.84 | CA1 (0.46) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL29395493 | 0.84 | CA1 (0.53) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL25852235 | 0.83 | MGLL (0.56) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL31526903 | 0.83 | CA1 (0.53) | GPR3MAPTALDH1A1HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117143030-B | Naphthyl substituted electricity-absorbing fragment compound, electron transport material and application | 烟台显华科技集团股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4254527-B1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2025-07-30 | — | — | EP | disclosed |
| EP-4410074-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2025-05-21 | — | — | EP | disclosed |
| CN-119930597-A | Organic compound, organic light emitting diode and organic light emitting device including the same | 乐金显示有限公司 | 2025-05-06 | — | — | CN | disclosed |
| WO-2025089913-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME | 덕산네오룩스 주식회사 | 2025-05-01 | — | — | WO | disclosed |
| CN-113328042-B | Organic electroluminescent element and preparation method thereof | 固安鼎材科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-4330257-B1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2025-03-19 | — | — | EP | disclosed |
| CN-119219589-A | Organic electroluminescent device containing asymmetric biaryl amine substituted dibenzofuran compound | 烟台显华科技集团股份有限公司 | 2024-12-31 | — | — | CN | disclosed |
| US-12167688-B2 | Light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-12-10 | — | — | US | disclosed |
| CN-119080763-A | Compound and organic electroluminescent element using same | 出光兴产株式会社 | 2024-12-06 | — | — | CN | disclosed |
| US-7985492-B2 | Electroluminescent materials and devices | MERCK PATENT GMBH (DE) | 2011-07-26 | — | — | US | disclosed |
| US-7985492-B2 | Electroluminescent materials and devices | MERCK PATENT GMBH (DE) | 2011-07-26 | — | — | US | disclosed |
| US-7772231-B2 | Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors | ABBOTT LABORATORIES (US) | 2010-08-10 | — | — | US | disclosed |
| EP-1973917-A2 | PROTEIN KINASE INHIBITORS | Abbott Laboratories (US) | 2008-10-01 | — | — | EP | disclosed |
| US-20070243410-A1 | Electroluminescent Materials and Devices | MERCK PATENT GMBH (DE) | 2007-10-18 | — | — | US | disclosed |
| US-20070243410-A1 | Electroluminescent Materials and Devices | MERCK PATENT GMBH (DE) | 2007-10-18 | — | — | US | disclosed |
| US-20070203143-A1 | PROTEIN KINASE INHIBITORS | ABBVIE INC. | 2007-08-30 | — | — | US | disclosed |
| WO-2007079164-A2 | PROTEIN KINASE INHIBITORS | ABBOTT LABORATORIES (US) | 2007-07-12 | — | — | WO | disclosed |
| EP-1773965-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | OLED-T LIMITED (GB) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006016193-A1 | ELECTROLUMINESCENT MATERIALS AND DEVICES | OLED-T LIMITED (GB) | 2006-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070243410-A1 | Electroluminescent Materials and Devices | ELAVL1, RUVBL2, ELAVL3 | GPR3 3168/4885MAPT 1488/4885ALDH1A1 1052/4885 |
| US-12167688-B2 | Light emitting device | LEF1, ALDH1A1, ESR1 | GPR3 2713/4885MAPT 2600/4885ALDH1A1 2/4885 |
| US-20070203143-A1 | PROTEIN KINASE INHIBITORS | PACSIN2, MAP3K20, PHKG1 | GPR3 3468/4885MAPT 1359/4885ALDH1A1 4453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.